Hospital program aims to shield vulnerable liver patients from dangerous pain meds
NCT ID NCT07249294
Summary
This study tests a hospital-wide program designed to prevent doctors from prescribing common painkillers like ibuprofen or metamizole to patients with advanced liver disease who are having major surgery. These medications can be dangerous for these patients, increasing risks of kidney problems, fluid buildup, and bleeding. The program uses alerts, updated guidelines, and team coordination to help medical staff choose safer pain management options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PORTAL HYPERTENSION RELATED TO CIRRHOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital del Mar
Barcelona, 08003, Spain
Conditions
Explore the condition pages connected to this study.